Benjamin Milgram

Benjamin Milgram began their work experience at Harvard University in 2007 as a Graduate Student and remained there until 2013. Following that, they joined Amgen in 2013 as a Scientist and later became a Senior Scientist in 2017, leaving the company in 2020. In 2020, Benjamin joined Scorpion Therapeutics as a Director of Chemistry and subsequently became the Senior Director of Chemistry in 2021.

Benjamin Milgram earned their Bachelor of Arts (B.A.) degree in Organic Chemistry from Northwestern University in 2007. Benjamin later went on to complete their Doctor of Philosophy (Ph.D.) in Organic Chemistry at Harvard University, finishing in 2013.